FDA, nasal spray and major depressive disorder

World’s first anti-depression nasal spray receives FDA approval
The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a
FDA approves 'ketamine' nasal spray for depression — here's everything you need to know
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.
Don’t use this nasal spray: FDA says it may cause ‘adverse’ effects
STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal spray that may cause “adverse” effects. The NasoGel was recalled by the manufacturer, NeilMed Pharmaceuticals Inc., the FDA said.
FDA expands approval for antidepressant nasal spray
The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat depression.
FDA recalls 90K bottles of nasal spray due to potential ‘adverse’ effects: Throw out ASAP
The recalled products were sold across 32 states — including Massachusetts, Connecticut, Rhode Island and Vermont.
FDA recalls over 89K bottles of nasal spray that may cause ‘adverse’ medical effects during flu season, throw out ASAP
If you suffer from allergies or sinus congestion, you might want to think twice before using this nasal spray. The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause “adverse” medical effects.
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.
PopSugar23d
Can a Nasal Spray Really Help Treat Depression? Here's What to Know About Spravato
Now, the Food and Drug Administration (FDA) has expanded approval for Johnson & Johnson's nasal spray, Spravato, to be used as a standalone treatment for people with severe depression who ...
WebMD19d
What to Know About the New Nasal Spray for Tough Depression
Jan. 27, 2025 – After years of limited options, people with hard-to-treat depression finally have a new standalone treatment. The FDA’s latest approval of the nasal spray Spravato (esketamine ...
Newsweek24d
FDA Approves Nasal Spray for Depression
This new treatment could help bring relief for millions of Americans struggling with depression. The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for ...
KOAT Albuquerque23d
Nasal spray approved to help treat depression
The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression. The drug, SPRAVATO, is made by Johnson & Johnson and was first approved in 2019 for ...
UPI24d
FDA approves Spravato, first monotherapy nasal spray to treat depression
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...
cbc.ca on MSN12d
'It changed my life tremendously': P.E.I.'s new ketamine clinic could offer mental health help
Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with ...
Quincy man becomes first Alzheimer’s patient to try nasal spray drug: ‘I’m hoping like heck’
Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...